Alexandre Puissant

15PUBLICATIONS
117CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursCancer diagnosisGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 08, 2026
Splicing-associated network PAK1-CLK1/4-SRRM1 is a vulnerability to overcome chemoresistance in human and mouse acute myeloid leukemia.

|May 07, 2026
Metabolic modulation of immune cell function: mechanisms and therapeutic implications in cancer immunotherapy.

|Jan 14, 2026
EGFR inhibitor-resistant lung cancers exhibit collateral sensitivity to a covalent, cysteine-independent KEAP1 oligomerizing molecular bridge.

Christopher F Bassil, Kerry Dillon, Gray R Anderson

|Dec 05, 2025
Pathway coessentiality mapping reveals complex II is required for de novo purine biosynthesis in acute myeloid leukaemia.

Amy E Stewart, Derek K Zachman, Pol Castellano-Escuder

|Jul 07, 2025
JAK2 inhibition mediates clonal selection of RAS pathway mutations in myeloproliferative neoplasms.

Nabih Maslah, Nina Kaci, Blandine Roux

|Mar 10, 2025
Pathway Coessentiality Mapping Reveals Complex II is Required for de novo Purine Biosynthesis in Acute Myeloid Leukemia.

Amy E Stewart, Derek K Zachman, Pol Castellano-Escuder

Pageof 3

Frequent Collaborators

7 joint publications

Kris C Wood

6 joint publications

Camille Lobry

5 joint publications

Raphael Itzykson

4 joint publications

Lina Benajiba